Vol. 90, Issue 3, 1049-1056, March 2001
The lung diffusing capacity for nitric oxide in rats is
increased during endotoxemia
John T.
Stitt and
Arthur B.
DuBois
John B. Pierce Laboratory, Yale University School of Medicine, New
Haven, Connecticut 06519
 |
ABSTRACT |
Rats, when injected with endotoxin, begin to
exhale nitric oxide (NO) within 1 h. This study measured the
diffusing capacity for NO in the lungs of rats
(DLNO) under both control and endotoxemic conditions, and it also estimated the rate at which endogenous NO
(
PNO) enters the distal compartment of
the lung, both in control rats and during endotoxemia.
DLNO increased from 0.68 ± 0.12 (SE)
ml · min
1 · mmHg
1 in
control rats to 1.17 ± 0.25 ml · min
1 · mmHg
1 in
endotoxemic rats.
PNO was 2.6 ± 0.5 nl/min in control rats and attained a value of 218.6 ± 50.1 nl/min at the height of NO exhalation 3 h after the endotoxin. We
suggest that increased DLNO reflects an
increase in pulmonary membrane diffusing capacity, caused by a
pulmonary hypertension that is due to neutrophil aggregation in the
lung capillaries. DLNO may also be increased by
an enlarged pulmonary capillary volume because of the vasodilatory
effects of the endogenous NO that is produced by the lung in response to the endotoxin. NO production by the lungs in response to endotoxin is unique in that it is the only situation reported to date in which
pathologically induced increases in NO exhalation originate from the
alveolar compartment of the lung, as opposed to the small conducting airways.
adult respiratory distress syndrome; lipopolysaccharides; lung
injury; pulmonary diffusing capacity
 |
INTRODUCTION |
RECENTLY, THERE HAS BEEN
CONSIDERABLE interest in the phenomenon of exhaled nitric oxide
(NO) gas in both humans and animals (1, 6, 7, 8, 12). It
has been proposed that a number of lung disorders, including
exacerbated asthma, bronchiectasis, and inflammatory responses, can
lead to increases in the concentrations of NO measured in expired air
(14, 17, 18). There is also good evidence that NO is both
produced and absorbed at different rates along the human airway. The
lowest NO concentrations are found in the alveolar expirate of the
lung, the conducting airways contain somewhat higher concentrations,
but by far the highest concentrations are measured in the
nasopharyngeal airway (6, 7, 19, 20). Obviously, the
concentration of NO that is measured in air at any particular level in
the airway is determined by the rate of production, the rate of its
absorption, and the rate of ventilation. Little can be concluded about
the nature of any increase in NO concentration in expired air from any
level of the respiratory tract unless both the rates of NO production and NO absorption at that particular site are known. Furthermore, unless proper precautions are taken during expirate sampling, contamination between regions can lead to erroneous results (6, 19, 20, 25).
Because of its pulmonary vasodilator properties, exogenously
administered NO, at concentrations of 20-50 parts per million (ppm), is now frequently used in the treatment of newborn pulmonary hypertension and during adult respiratory distress syndrome, or ARDS
(22, 23). However, the manner in which NO diffuses across the lung into the pulmonary circulation and the ultimate fate of this
inhaled NO have not been thoroughly studied nor are they well
understood (2-4). NO is thought to be avidly
scavenged by the red blood cells and irreversibly bound to hemoglobin
as methemoglobin, although recently Stamler's group (Jia et al., Ref.
16) has postulated that the NO molecule can be bound by
thiol bonds to cysteine residues on the amino termini of the
hemoglobin rather than by the heme moiety. Furthermore, the blood
oxygen tension (PO2) is postulated to affect
the nature of this form of NO binding and thereby regulate
allosterically the loading and unloading of NO by the hemoglobin
molecule at different sites within the circulation, depending on the
prevailing PO2 levels of the blood. However,
the importance of this concept has recently been challenged (9) and therefore must still be regarded as unsubstantiated.
The recent literature in this area has mainly been concerned with
increases in NO concentrations that are detected within the smaller
conducting airways, related to the exacerbation of asthma and other
inflammatory conditions (8, 17, 18, 25). Little attention
has been paid to the alveolar compartment per se, because it is thought
that all NO in this compartment is removed by the pulmonary circulation
(5). However, although it is realized that the lung
alveoli play a major role in the uptake of NO (e.g., absorbing the NO
that is picked up during the passage of inhaled air through the
nasopharyngeal region in humans), they may also produce NO. There have
been a few reports in the literature documenting very low levels of NO
[<5.0 parts per billion (ppb)] in end-tidal expired air. Hyde et al.
(14) measured both the rate of production and the rate of
uptake of NO in the distal portion of the healthy human lung and
speculated on how they might be affected during conditions of lung
injury. However, to our knowledge, there has been no systematic study
of the production and absorption of NO by the alveolar portion of the
lung during lung injury. We are particularly interested in this
problem, because we have observed high concentrations of NO in the
mixed-expired air of rats in which acute lung injury was initiated
by endotoxemia (28, 30). We postulated that this exhaled
NO is produced in response to an indirect action of endotoxin on the
pulmonary capillary endothelium and that this endogenous NO crosses the
pulmonary blood-to-air membrane, enters the alveolar compartment of the
lung, and a portion of it is then exhaled in the end-tidal gas.
Rats that have been injected intravenously with a lipopolysaccharide
(LPS) endotoxin soon begin to exhibit high concentrations of NO gas in
their exhaled air (26, 28, 30). This increase in NO
concentration first appears within 60 min after the LPS injection,
reaches a plateau at ~3 h, and then gradually declines during the
next 6-h period. We have shown that the NO is produced from within the
lungs and is not carried to the lungs and unloaded there by the
systemic circulation. We have evidence that circulating neutrophils are
essential for this NO response to occur and that an interaction between
the LPS-activated neutrophils, aggregating within the lung vasculature,
and the lung capillary endothelium appears to be the cause of the
production of NO by the lung (13, 26, 29, 30).
Our previous study demonstrated that, despite the fact that they were
producing endogenous NO from within their lungs, endotoxemic rats were
capable of absorbing more NO when it was inhaled from an exogenous
source than were control rats (29). The purpose of this
study was to compare the NO diffusing capacity of the rat lung
(DLNO) under control and endotoxemic conditions
and also to determine the rate of production of endogenous NO
(
PNO) by the lungs in both the control
and endotoxemic, LPS-treated states. In this study the measurement of
the rate of NO exchange was confined to the distal portion of the
respiratory tract in rats for the following three reasons. First, the
rats were tracheotomized to the level of the carina; second, the
frequency of ventilation chosen (60 breaths/min) virtually eliminated
the conducting airways as significant contributors to the NO
concentration in the exhaled air; and, finally, when end-tidal samples
of exhaled NO were compared with samples of the mixed-expired gas,
physiological dead space was calculated to be, as expected, ~25% of
tidal volume. End-tidal vs. mixed-expired CO2 samples
yielded a similar physiological dead space fraction.
The steady-state lung diffusion capacity for any suitable inhaled gas
is determined by measuring the rate of uptake of that gas across the
alveolar membrane into the circulation at a known partial pressure of
the gas within the alveolar compartment minus the back pressure from
the blood. The most commonly used gas in such studies is carbon
monoxide (CO) because of its low solubility and its ability to bind
preferentially to hemoglobin (2-4). Recently, there
has been a renewed interest in the lung diffusion of NO because of the
widespread therapeutic use of inhaled NO in the treatment of pulmonary
hypertension or lung injury, such as ARDS. NO has properties similar to
CO that make it suitable for the determination of lung diffusion
capacity, although it is more than twice as soluble as CO in aqueous
solution (4, 11), which in turn increases its lung
membrane diffusion coefficient. It binds very tightly with blood
hemoglobin to form methemoglobin, thus reducing the back pressure from
the blood. The derivations of the equations used to determine
steady-state DLNO and the determination of
PNO in control and endotoxemic rats are
contained in the APPENDIX.
 |
MATERIALS AND METHODS |
The animals used in this study were five male Sprague-Dawley
rats weighing between 250 and 350 g. They were first anesthetized with pentobarbital sodium (50 mg/kg ip) and then tracheotomized, and a
catheter was inserted via the left femoral vein and advanced to the
inferior vena cava. The animals were placed supine and paralyzed with
gallamine triiodate (15 mg/kg iv). The endotracheal tube was attached
to a Harvard small animal ventilator and set for a minute ventilation
rate of 180 ml/min, a tidal volume (VT) of 3.0 ml, and a
respiratory frequency rate of 60/min. Air supplied to the intake port
of the ventilator was cleansed of ambient NO by drawing it through a
permanganate/charcoal absorber attached to the intake. Anesthesia was
maintained during the experiments by intravenously infusing a solution
of pentobarbital (6.0 mg/ml) and gallamine (4 mg/ml) contained in 0.9%
NaCl at a rate of 1.0 ml/h. Systemic arterial blood pressure was
measured by a Statham transducer connected to a PE-60 catheter inserted
into the left common carotid artery. The preparation is illustrated in
Fig. 1.
Experiments were conducted at an ambient temperature of 22°C between
0800 and 1600; rectal temperature was monitored continually throughout
each experiment and was kept above 37°C by the intermittent application of infrared heat. Mixed-expired air was continuously withdrawn from the ventilator outflow via a 10-ml exhaust plenum at a
rate of 18 ml/min and passed through a Sievers 270B chemiluminescence NO detector that had both a detection threshold and a sensitivity of
~1.0 ppb for gaseous NO, allowing us to determine continuously the
fraction of NO in mixed-expired gas (FENO). The
fraction of NO in the end-tidal gas (FANO) was
measured by using a solenoid-actuated valve, driven by the ventilator
to repeatedly sample, via a sidearm on the endotrachial tube, the final
0.3-ml fraction of each VT exhaled. Because the ventilation
rate was 60/min, this meant that a quasi-continuous flow of end-tidal
air (~18 ml/min) passed through the NO detector as demanded by the
vacuum pump. Both the mixed-expired and end-tidal circuits were
independently tested for leaks by replacing the rat with an
"artificial" lung (the airtight finger of a vinyl glove, having a
volume of ~6 ml), which was attached to the endotracheal tube. A
5-liter Tedlar bag containing a known concentration of NO (previously
determined directly by the NO meter) was attached to the intake port of
the ventilator, and the "vinyl lung" was ventilated with this gas,
just as in a normal experiment. We could divert sampling from the
"mixed-expired" to the "end-tidal" circuit by turning a
three-way stopcock and thus compare the two NO concentrations being
measured. Because this lung did not absorb any NO, the
end-tidal values exactly matched the mixed-expired values, and both
were identical to the NO concentration of the gas mixture in the bag
that was supplying the vinyl lung via the intake port of the
ventilator. In this manner, we assured ourselves that there were no
leaks in either the mixed-expired or the end-tidal circuits and that
there was no sample dilution.
The results using this technique are illustrated by Fig.
2, which shows an experiment in which an
LPS-treated rat is breathing NO-free air. It can be seen that the
appearance of NO in mixed-expired air starts at ~60 min and reaches a
plateau at +3 h. End-tidal values were measured where indicated, by use
of the endotracheal sidearm, and it can be seen that
FANO exceeds FENO by
the ratio of the ventilatory dead space. Mixed-expired and end-tidal
values of CO2 were also measured by passing the
mixed-expired or the end-tidal samples through a Beckman infrared
CO2 meter, placed in series before the NO analyzer.
Mixed-expired CO2 was lower than end-tidal CO2
by ~25%, and end-tidal gas concentrations were used as an estimate
of alveolar gas concentrations. Calculation of the physiological dead
space (VD) by using VT,
FEGAS, and FANO for
inhalation of NO, exhaled NO, and exhaled CO2,
respectively, yielded identical values for VD. This
permitted us to calculate (VT
VD) and,
hence, alveolar ventilation (
A). Deeper sighs (twice
normal, i.e., VT ~6 ml) were induced once every 10 min to
minimize lung atelectasis.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
An example of the development of nitric oxide (NO) in the
mixed-expired gas of an endotoxin-treated rat. It can be seen that, at
each point in time, the NO concentrations in the 3 end-tidal samples
shown exceed those of the comparable mixed-expired samples.
[NO]A and [NO]E, end-tidal and expired NO
concentration, respectively; LPS, lipopolysaccharide; ppb, parts per
billion.
|
|
The LPS endotoxin (prepared from Escherichia coli, batch no.
82F-4012) was purchased from Sigma Chemical (St. Louis, MO). It was
dissolved in sterile 0.9% saline, and all injections were made at a
dose of 1.0 mg/kg via the femoral/vena caval catheter.
The ability of the lungs to extract inhaled NO was measured by
connecting three different concentrations of NO (approximately at 600, 1200, and 1,800 ppb), carried in air in a Tedlar bag attached to the
intake port of the ventilator for 4 min, and by measuring the
respective concentrations of NO in the resulting mixed-expired and
end-tidal samples. This was first performed in a randomized fashion on
each rat to obtain control NO uptake values and was then repeated
3 h after the induction of endotoxemia. The plots of the
mixed-expired concentrations of NO ([NO]E) and the
end-tidal concentrations of NO ([NO]A) vs. the inspired
concentrations of NO ([NO]I) yielded regression lines
whose slopes (m) described the fraction of NO that was not
absorbed by the whole lung (mENO) or
by the alveoli (mANO), first under
control and then during endotoxemic conditions. These values,
determined by data taken from the five rats, were used to calculate
values for DLNO under control and then under
endotoxemic conditions. We also calculated the rate at which
endogenously produced NO entered the lungs during control and
endotoxemic conditions, using the equations whose derivations are
described in the APPENDIX. Time control experiments had
been conducted previously to ensure that ventilation of the animals for
a period of >3 h, per se, did not alter the ability of their lungs to
extract inhaled NO (29).
Statistical analyses of the data were carried out using standard
unpaired t-tests, regression analysis, and, where
appropriate, ANOVAs. When data were averaged, means ± SE are
given. Statistical significance was assumed at the level of
P < 0.05.
 |
RESULTS |
Figure 3 illustrates the uptake of
inhaled NO in control rats, in which both [NO]E and
[NO]A are plotted for three different levels of
[NO]I over a range of 500-2,000 ppb. The slopes of
the resulting two regression lines intersect close to the axis at [NO]I = [NO]E = [NO]A = 5.3 ppb, indicating that little endogenous NO is produced by control rats.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 3.
NO uptake measured in the 5 rats during the control
period. Both [NO]E and [NO]A samples are
plotted at a variety of inhaled NO concentrations
([NO]I). Slopes were determined by a least squares
regression analysis. VT, tidal volume; VD, dead
space volume.
|
|
Measurement of [NO]E and [NO]A, taken when
[NO]I = 0, show that they are 3.2 ± 0.2 and
4.2 ± 0.2 ppb, respectively. The slopes of the two lines
represent the NO fraction that remains unabsorbed in the entire
lung, including VD
(mENO = 0.41 ± 0.02), and in the end-tidal compartment (mANO = 0.22 ± 0.02). These two values, along with VT,
permitted us to calculate VD and thus (VT
VD) and to evaluate DLNO, by use of
Eq. 1
|
(1)
|
where (VT
VD) = 2.27 ± 0.14 ml; respiratory frequency (RF) = 60 breaths/min;
PB
PH2O = 713 Torr;
A = (VT
VD) × RF = 136.2 ± 8.1 ml/min ATP;
mANO = 0.22 ± 0.02;
DLNO = 136.2 ml/min·(1
0.22)/(713 Torr · 0.22); and DLNO = 0.68 ± 0.12 ml·min
1·Torr
1.
PB represents barometric pressure.
Additionally, the rate of entry of endogenously produced NO into the
alveolar compartment of the lungs of the control rats was calculated
using Eq. 2
|
(2)
|
where FANO = 4.2 ± 0.2 × 10
9, when FINO = 0;
A = 136.2 ± 8.1 ml/min at ATP;
PB
PH2O = 713 Torr;
DLNO = 0.68 ± 0.12 ml · min
1 · Torr
1.
PNO = 4.2 × 10
9·[136.2
ml/min + (713 Torr·0.68
ml·min
1·Torr
1)];
PNO = 2.6 ± 0.5 × 10
6 ml/min.
The amount of endogenous NO that is produced by control rats is very
small, such that, when rats were breathing NO-free air, FENO and FANO were
3.2 ± 0.2 and 4.2 ± 0.2 ppb, respectively, and were
therefore just measurable by the Sievers NO analyzer, which had a
detection threshold of ~1 ppb.
The rats were then made endotoxemic by injecting them with LPS, and we
waited 3 h until exhalation of endogenous NO reached its plateau
level (namely, Fig. 2). The NO uptake experiments were repeated, and
the results obtained are summarized in Fig. 4.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 4.
NO uptake measured in the same 5 rats at 3 h after
induction of endotoxemia. Both [NO]E and
[NO]A samples are plotted for a variety of
[NO]I. The slopes were determined by a least squares
regression analysis. The line of identity, where [NO] exhaled = [NO] inhaled is also shown, illustrates that all 3 lines intersect at
a single point (261.5 ppb).
|
|
It is noted that slopes of the two lines are reduced compared with the
control animals (mENO = 0.35 ± 0.02; mANO = 0.14 ± 0.02) and
that they intersect on the line of identity, in which [NO]E = [NO]A = [NO]I = 261.5 ppb. This attests to the accuracy of
the measurements that we performed. Furthermore, when
[NO]I = 0, it can be seen that
[NO]A = 224.7 ppb and [NO]E = 169.9 ppb. Because [NO]A > [NO]E,
this confirms that endogenously produced NO comes from the alveolar
compartment rather than from the conducting airways, which are dead
space. DLNO was again calculated using Eq. 1, where (VT
VD) = 2.27 ± 0.12 ml; RF = 60 breaths/min; PB
PH2O = 713 Torr;
A = (VT
VD) × RF = 136.2 ± 7.2 ml/min ATP; mANO = 0.14 ± 0.02; DLNO = 136.2 ml/min · (1
0.14)/(713 Torr · 0.14); and DLNO = 1.17 ± 0.25 ml·min
1·Torr
1.
The rate of entry of the endogenously produced NO into the alveolar
compartment of the endotoxemic rats was calculated using Eq. 2, where FANO = 224.7 ± 7.6 × 10
9 when FINO = 0;
A = 136.2 ± 7.2 ml/min at ATP;
PB
PH2O = 713 Torr; and
DLNO = 1.17 ± 0.25 ml·min
1 · Torr
1.
PNO = 224.7 × 10
9
· [136.2 ml/min + (713 Torr·1.17
ml·min
1 · Torr
1)]; and
PNO = 218.6 ± 50.1 × 10
6 ml/min.
Of the 218.6 nl of endogenous NO entering the lungs each minute, 0.86 (188 nl) leaves by diffusion out into the pulmonary circulation,
whereas 0.14 (30.6 nl) remains within the alveolar compartment and is
exhaled at an end-tidal concentration of 30.6 nl/136.2 ml = 224.7 ppb = [NO]A when [NO]I = 0.
To illustrate both between-animal variability and the
reproducibility of our technique, Table 1
contains estimates of both DLNO and
PNO, calculated using individual data
from the five rats in the study. It can be seen that the range of
DLNO in normal rats was 0.53 to 0.86, with a
mean of 0.68 ± 0.08 ml·min
1 · Torr
1, and
PNO varied from 2.0 to 3.0 with a mean
of 2.6 ± 0.21 nl/min. When the rats were made endotoxemic,
DLNO had a range of 0.87 to 1.39 with a mean
value of 1.18 ± 0.11 ml·min
1 · Torr
1, and
PNO varied from 158.1 to 280.7 with a
mean value of 220.9 ± 20.7 nl/min. These mean values are not very
different from those calculated with the pooled data, and, indeed,
their overall variability is actually somewhat less.
 |
DISCUSSION |
A "steady-state" determination of lung diffusion capacity, as
opposed to other methods such as "single breath" or
"rebreathing" techniques, is usually regarded as a more
physiologically useful method of determining gas uptake by the lung.
This is because it is determined under conditions of normal,
uninterrupted respiration and at normal tidal volumes, although such a
determination might be criticized on the grounds that it is also more
subject to inhomogenieties of both regional ventilation and perfusion
within the lung. The method we used relies on the determination of the
fraction of inspired NO that remains in end-tidal air at several
different values of FINO. It permitted us to
demonstrate that NO uptake was linear over a range of different gas
concentrations and then to average this NO uptake by determining the
slope of the line obtained by plotting FANO as
a function of FINO. Furthermore, by determining
both FENO and FANO
simultaneously for each level of FINO, we were
able to determine the Bohr dead space for NO and use it to calculate
alveolar ventilation and to show that the preponderance of NO uptake
occurred within the end-tidal region of the lung. The respiratory rate
of 60 breaths/min that we used (normal for rats) also ensured that any
contamination of the end-tidal air by "conducting airway NO,"
picked up during its passage through the lower conducting airways, was
negligible. This meant that the end-tidal samples were more
representative of true alveolar gas. Alveolar tidal volume
(VT
VD) was calculated using
FENO and FANO according
to the equation
|
|
and more generally by
|
|
The fact that the calculated dead spaces for CO2
and NO are identical might at first sight seem a bit surprising.
However, we are sure that this is not due to sample dilution in the
measurement of either the mixed-expired or the end-tidal gas
concentrations. Our reasons are as follows. First, we independently
verified the accuracy of both measurements. Second, when the
CO2 dead space is calculated, it is based on the assumption
that the dead space contains no CO2 and that all
CO2 in the mixed-expired sample comes from the end-tidal
compartment. Thus [CO2]A is greater than
[CO2]E, and the difference between
[CO2]A and [CO2]E,
along with the tidal volume, is used to calculate the dead space.
However, in the case of calculating the NO dead space, we used two
different methods. First, as can be seen in Fig. 3, when normal animals
are ventilated with an NO gas mixture, [NO]A is less than
[NO]E, because the lungs absorb more NO than they
produce. Thus, in this case, NO dead space is calculated with the
assumption that the NO in the dead space remains unabsorbed. However,
in the case of endotoxemic rats (Fig. 2), when the animals breathe
NO-free air, [NO]A is greater than [NO]E
and, as in the case of CO2, the assumption is that all NO
in the mixed-expired sample comes from the end-tidal compartment. Both
calculations yield identical NO dead spaces, which also agree with the
calculated CO2 dead space. When endotoxemic rats are
ventilated with NO gas mixtures (Fig. 4), once the concentration of NO
in the inspired gas mixture exceeds that of the endogenous end-tidal NO
concentration, [NO]A becomes less than
[NO]E because there is now a net absorption of NO;
however, the calculation of NO dead space yields a similar result.
Finally, the fact that in Fig. 4 the two lines representing
mixed-expired and end-tidal concentrations intersect exactly on the
line of identity also strongly militates against any errors in sample measurement.
We suggest that the reason that the CO2 and NO dead spaces
are similar has more to do with the nature of the dead spaces
themselves. In the first place, the physiological dead space is small
(~0.73 ml, which is ~25% of the tidal volume employed in the
study). Furthermore, because the trachea is cannulated to the level of the carina, a significant part of this dead space is inert tubing, thus
reducing the portion of total dead space that is even available for gas
exchange. The frequency of respiration (60 breaths/min) reduces
residence time of the gas within the dead space, thereby further
reducing the opportunity for gas exchange. For these reasons, we think
that the dead space gas exchange of NO is negligible in tracheotomized
rats and therefore that the CO2 and NO dead spaces are identical.
In the case of the control rats, because VT was always set
at 3.0 ml and mENO and
mENO were 0.41 ± 0.02 and
0.22 ± 0.02, respectively, as determined by the slopes of the two
lines in Fig. 3, this yielded a value for (VT
VD) = 2.27 ± 0.14 ml. The (VT
VD) value accorded well with the value for (VT
VD) as determined by using
FECO2 and
FACO2; this demonstrates that
virtually all of the NO uptake occurred in the alveolar compartment of
the lung, as might be expected from the argument we have just made.
The extremely low concentrations of endogenous NO that were detected in
both mixed-expired and end-tidal air when the control rats were
breathing NO-free air (3.2 and 4.2 ppb, respectively) indicate that
very little NO is produced within the normal rat lung. When we
calculated a value for
PNO during the
control period, according to Eq. 2, the result was 2.6 nl/min. It is interesting to note that Hyde et al. (14),
using the "breathholding" technique in normal humans, calculated
that the distal lung produced NO at a rate of 540 nl/min
(14). When we consider that the mass of humans is ~200
times that of rats (70 vs. 0.30 kg), there is a surprising scalar
congruity between Hyde's results and our own. Indeed, this scalar
congruity also extends to the value for DLNO that we determined for normal rats. To our knowledge, there are no published data on the diffusing capacity for NO in rats. However, our value of 0.68 ml·min
1·Torr
1
(2.3 ml·min
1·Torr
1 · kg
1)
compares very favorably with the published values of 140-150 ml·min
1·Torr
1
for humans (2.1 ml· min
1·Torr
1·kg
1)
(10, 13) and that for dogs at 54.0 ml·min
1·Torr
1
(2.6 ml·min
1·Torr
1·kg
1)
(20). This seems to accord well with the proposal of
Weibel (32) that lung diffusing capacity is directly
proportional to perfused lung surface area and, hence, to body mass
(32).
When rats were made endotoxemic, the concentrations of NO in the
mixed-expired and end-tidal samples rose to an average of 170 and 225 ppb, respectively, by the end of 3 h. Several conclusions may be
drawn. First, because the end-tidal concentration exceeded the
mixed-expired concentration, it is clear that this NO was coming from
the alveolar compartment. Furthermore, calculated (VT
VD) remained unchanged at 2.27 ± 0.12 ml, and the
ratio of the NO concentrations in the mixed-expired and end-tidal gases (170/225 = 0.76) is exactly equal to the ratio of (VT
VD) to VT (2.27/3.00 = 0.76),
indicating that endogenously produced NO came entirely from the
end-tidal compartment of the lung and not from the dead
space-conducting airways. When uptake of exogenous NO was measured in
the endotoxemic rats after their endogenous NO production had reached
its plateau, the residual fraction of NO in both the mixed-expired
(mENO = 0.35 ± 0.02) and
end-tidal (mANO = 0.14 ± 0.02)
fractions was less (P < 0.01) than it was for the
normal rats (mENO = 0.41 ± 0.02 and mANO = 0.22 ± 0.02, respectively). This indicated that lung uptake of NO had increased, and, by using Eq. 1, we determined that
DLNO had increased by 73% from 0.68 to 1.17 ml·min
1·Torr
1.
It also confirmed our earlier observation that the uptake of inhaled
exogenous NO was greater in LPS-treated rats than in normal rats,
despite the fact that the endotoxemic rats were also producing significant amounts of endogenous NO within the alveolar compartment (29). Using Eq. 2, we calculated that, on
average,
PNO increased almost 85-fold,
from 2.6 nl/min in the control state to 218.6 nl/min during endotoxemia.
Given this demonstrated increase in the avidity of their lungs for NO,
it may seem surprising that endotoxemic rats actually exhale any NO
from the alveolar compartment. However, at the alveolar ventilation
employed, although the majority (~86%) of inhaled NO entering the
alveolar compartment is taken up by the pulmonary circulation, the
remaining portion (~14%) is exhaled. We assume that this uptake is
equally as true for endogenously produced NO as it was for inspired
exogenous NO. We propose that the endogenous NO is produced by
the action of adherent neutrophils on the capillary endothelial cells
in the pulmonary circulation and that a measurable proportion of this
NO finds its way into the alveolar compartment, whence it is exhaled in
the end-tidal air. This represents more of a lung vascular response to
LPS than a lung parenchymal response, and it is different from the
asthmatic condition, in which small airway inflammatory responses are
thought to be responsible for the increased NO concentrations in the
exhaled air (14, 17, 18, 25).
At this point, we can only speculate about the mechanisms that
produce the large increase in the diffusing capacity for NO in the
endotoxemic rat lung. According to the widely accepted Roughten and
Forster (24) model, overall diffusing capacity of the lung
for a gas results from a combination of the diffusing conductance of
the lung gas-blood membrane barrier, the gas uptake conductance of the
erythrocytes per unit blood volume (
), and the lung capillary blood
volume (Vc). Thus, for NO diffusion, these factors are related
according to the equation
where DmNO is NO membrane diffusing
capacity. To increase DLNO from 0.68 to 1.17 ml · min
1 · Torr
1 would
require a substantial increase in one or more of the three components
that comprise DLNO, namely,
DmNO,
NO, and Vc. It seems unlikely that the erythrocyte NO uptake conductance (
NO)
would be altered by endotoxin because it is governed by the hemoglobin content of the blood cells and pulmonary ematocrit. This then leaves
the membrane conductance and/or pulmonary Vc as possible sources of
increased uptake of NO. Although one might readily conceive that an
increase in lung capillary volume could occur in response to locally
produced NO, because NO is a vasodilator (15, 31), it
seems unlikely that this alone could bring about an increase in
DLNO of the magnitude that we observed. The major resistance to diffusion of NO across the lung is believed to reside in
the alveolar membrane component, rather than in the blood component; indeed, several studies have proposed that the
(
NO × Vc) component has an almost infinite
conductance (11).
Thus we are led to the conclusion that endotoxin also acts to increase
DmNO. This could be caused by the increased capillary pressure and vascular congestion within the pulmonary circulation that
is caused by LPS (10, 13, 29). The pulmonary hypertension that occurs during the early phase of endotoxin-induced lung injury appears to be due to an aggregation of neutrophils within the lung
capillaries, which eventually leads to pulmonary edema (13, 26,
29). This hypertension would increase both the lung Vc and the
portion of the total alveolar/capillary network within the lung that is
perfused or blood filled, thereby increasing the area of lung
vasculature that is available for NO diffusion and uptake. An
additional possible cause for the increase in DLNO is the
increase in cardiac output and
O2 that
accompanies both the febrile and early "cardiodynamic" stages
of endotoxemia. It is well established that both factors increase lung
diffusion capacity, in the same manner that exercise increases the
oxygen diffusing capacity of the lung (32). For example,
Meyer et al. (21) demonstrated that, by using
dinitrophenol to increase the cardiac output and
O2 in anesthetized dogs, they could
increase DLNO by >50%.
In conclusion, we have demonstrated that the intravenous action of LPS
on rats causes an increase in the production of NO within the alveolar
compartment of the lungs, while it concurrently increases the diffusing
capacity of the lungs for NO uptake. This phenomenon is different from
previously described pathological conditions in which exhaled NO
concentrations are increased, because the increased NO arises from the
alveolar compartment of the lungs, and its source appears to be the
vascular component of the lungs, rather than the airway smooth muscle.
We believe that this early manifestation of NO in the expired air of
endotoxin-treated rats is a very prompt and reliable marker for the
onset of the acute lung injury that is caused by septicemia.
 |
APPENDIX |
Determining the Diffusing Capacity of Rat Lungs
However, FANO may also be
defined as FANO = mANO·[FINO + (
PNO/
A)]
or
FANO/mANO = FINO + (
PNO/
A), where
mANO is the fraction of the
theoretical initial concentration of NO that remains in the alveoli
after diffusion occurs. Substituting into Eq. A3, we get
|
(A4)
|
|
(A5)
|
However, because FANO = PANO/(PB
PH2O), substituting this into Eq. A5
we get
|
(1)
|
Equation 1 is from the text; and
mANO is evaluated by plotting
FANO against FINO for
several different values of FINO and determining the slope of the resulting regression line.
Determining the Rate of Endogenous NO Production in Rat Lungs
However, when rats are breathing NO-free air, then
FINO = 0
|
(2)
|
where FANO is the alveolar concentration
when rats are breathing NO-free room air (i.e., when
FINO = 0).
 |
FOOTNOTES |
Address for reprint requests and other correspondence: J. T. Stitt, John B. Pierce Foundation Laboratory, 290 Congress Ave., New
Haven, CT 06519.
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 1 August 2000; accepted in final form 15 September 2000.
 |
REFERENCES |
1.
Aaron, SD,
Valenza F,
Volgeyesi G,
Mullen JB,
Slutsky AS,
and
Stewart TE.
Inhibition of exhaled nitric oxide production during sepsis does not prevent lung inflammation.
Crit Care Med
26:
309-314,
1998[Web of Science][Medline].
2.
Azoulay, E,
Soler P,
Blayo MC,
and
Basse F.
Nitric oxide effects on lung structure and blood oxygen affinity in rats.
Bull Eur Physiopathol Respir
13:
623-644,
1977.
3.
Borland, C,
Chamberlain A,
and
Higenbottam T.
The fate of inhaled nitric oxide.
Clin Sci (Colch)
65:
37P,
1983.
4.
Borland, CDR,
and
Cox Y.
Effect of varying alveolar oxygen partial pressure on diffusing capacity for nitric oxide and carbon dioxide, membrane diffusing capacity and lung capillary blood volume.
Clin Sci (Colch)
81:
759-765,
1991[Medline].
5.
Byrnes, CA,
Denarevic J,
Busst C,
Bush A,
and
Shinebourne EA.
Is nitric oxide in exhaled air produced at the airway or alveolar level?
Bull Eur Respir J
13:
623-644,
1997.
6.
DuBois, AB,
Douglas JS,
Stitt JT,
and
Mohsenin V.
Production and absorption of nitric oxide gas in the nose.
J Appl Physiol
84:
1217-1224,
1998[Abstract/Free Full Text].
7.
DuBois, AB,
Kelly PM,
Douglas JS,
and
Mohsenin V.
Nitric oxide production and absorption in trachea, bronchi, bronchioles, and respiratory bronchioles of humans.
J Appl Physiol
86:
159-167,
1999[Abstract/Free Full Text].
8.
Gaston, B,
Drazen JM,
Loscalzo J,
and
Stamler JS.
The biology of nitrogen oxides in the airways.
Am J Respir Crit Care Med
149:
538-551,
1994[Abstract].
9.
Gladwin, MT,
Shellhamer JH,
Pannell LK,
Nichols JS,
Pease-Fye ME,
Schecter AN,
and
Ognibene FP.
The role of hemoglobin in the transport and metabolism of nitric oxide in the human circulation (Abstract).
Am J Respir Crit Care Med
161:
A848,
2000.
10.
Gryglewski, RJ,
Wolkow PP,
Yracz W,
Janowska E,
Bartus JB,
Balbatun O,
Patton S,
Bravkovych N,
and
Malinski T.
Protective role of pulmonary nitric oxide in the acute phase of endotoxemia in rats.
Circ Res
82:
819-827,
1998[Abstract/Free Full Text].
11.
Guenard, H,
Varene N,
and
Vaida P.
Determination of lung capillary blood volume and membrane diffusing capacity in man by the measurements of NO and CO transfer.
Respir Physiol
70:
113-120,
1987[Web of Science][Medline].
12.
Gustaffson, LE,
Leone AM,
Persson MG,
Wiklund NP,
and
Moncada S.
Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans.
Biochem Biophys Res Commun
181:
852-857,
1991[Web of Science][Medline].
13.
Haslett, C,
Worthen GS,
Giclas PC,
Morrison DC,
Henson JE,
and
Henson PM.
The pulmonary vascular sequestration of neutrophils in endotoxemia is initiated by an effect of endotoxin on the neutrophil in the rabbit.
Am Rev Respir Dis
136:
9-18,
1987[Web of Science][Medline].
14.
Hyde, RW,
Geigel EJ,
Olszowka AJ,
Krasney JA,
Forster RE, 2nd,
Utell MJ,
and
Frampton MW.
Determination of production of nitric oxide by lower airways of humans
theory.
J Appl Physiol
82:
1290-1296,
1997[Abstract/Free Full Text].
15.
Ignarro, LJ,
Buga GM,
Wood KS,
Byrns RE,
and
Chaudhuri G.
Endothelial derived relaxing factor produced and released from artery and vein is nitric oxide.
Proc Natl Acad Sci USA
84:
9265-9271,
1987[Abstract/Free Full Text].
16.
Jia, L,
Bonaventura C,
Bonaventura J,
and
Stamler JS.
S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control.
Nature
380:
221-226,
1996[Medline].
17.
Kharitinov, SA,
Wells AU,
O'Connor BJ,
Hansell DM,
Cole PJ,
and
Barnes PJ.
Elevated levels of nitric oxide in bronchiectasis.
Am J Respir Crit Care Med
151:
1889-1893,
1995[Abstract].
18.
Kharitinov, SA,
Yates AD,
Springall DR,
Buttery L,
Polak J,
Robbins RA,
and
Barnes PJ.
Exhaled nitric oxide is increased in asthma.
Chest
107:
156S-157S,
1995[Free Full Text].
19.
Lundberg, JO,
Rinder J,
Weitzberg E,
Lundberg JM,
and
Alving K.
Nasally exhaled nitric oxide in humans originates mainly in the paranasal sinuses.
Acta Physiol Scand
152:
431-432,
1994[Web of Science][Medline].
20.
Lundberg, JON,
Weitzberg E,
Lundberg JM,
and
Alving K.
Nitric oxide in exhaled air.
Eur Respir J
9:
2671-2680,
1996[Abstract].
21.
Meyer, M,
Schuster KD,
Schulz H,
Mohr M,
and
Piiper J.
Pulmonary diffusing capacities for nitric oxide and carbon monoxide determined by rebreathing in dogs.
J Appl Physiol
68:
2344-2357,
1990[Abstract/Free Full Text].
22.
Michael, JR,
Barton RG,
Saffle JR,
Mone M,
Markewitz BA,
Hillier K,
Elstad MR,
Campbell EJ,
Tryer BE,
Whateley RE,
Liou TG,
Samuelson WM,
Carveth HJ,
Hinson DM,
Morris SE,
Davis BL,
and
Day RW.
Inhaled nitric oxide vs. conventional therapy.
Am J Respir Crit Care Med
157:
1372-1380,
1998[Abstract/Free Full Text].
23.
Rossaint, R,
Falk KJ,
Lopez F,
Slama K,
Pison U,
and
Zapol WM.
Inhaled nitric oxide for the adult respiratory distress syndrome.
N Engl J Med
328:
399-405,
1993[Abstract/Free Full Text].
24.
Roughten, FJW,
and
Forster RE.
Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lungs, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries.
J Appl Physiol
11:
290-302,
1957[Abstract/Free Full Text].
25.
Recommendations for standard procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children
1999.
Am J Respir Crit Care Med
160:
2104-2117,
1999[Free Full Text].
26.
Simpson, R,
and
Hechtman HB.
Pulmonary injury following sepsis.
In: Bacterial Endotoxins: Basic Science to Anti-Sepsis Strategies, , edited by Levin J,
van Deventer SJH,
van der Poll T,
and Sturk A.. New York: Wiley-Liss, 1994, p. 265-275.
27.
Stewart, TE,
Valenza F,
Ribiero SP,
Volgeysi G,
Millen JMB,
and
Slutsky AS.
Increased nitric oxide in exhaled gas as an early marker in lung inflammation in a model of sepsis.
Am J Respir Crit Care Med
151:
713-718,
1995[Abstract].
28.
Stitt, JT,
DuBois AB,
and
Douglas JS.
Large rise in nitric oxide (NO) in the alveolar gas of endotoxin treated rats (Abstract).
FASEB J
9:
A132,
1995.
29.
Stitt, JT,
DuBois AB,
Douglas JS,
and
Shimada SG.
Exhalation of gaseous nitric oxide by rats in response to endotoxin and its absorption by the lungs.
J Appl Physiol
82:
305-316,
1997[Abstract/Free Full Text].
30.
Stitt, JT,
Shimada SG,
and
Douglas JS.
Neutropenia abolishes the production of nitric oxide by the lungs of endotoxin treated rats (Abstract).
FASEB J
10:
A4683,
1996.
31.
Vincent, J-L,
Zhang H,
Szabo C,
and
Preiser J-C.
Effects of nitric oxide in septic shock.
Am J Respir Crit Care Med
161:
1781-1785,
2000[Abstract/Free Full Text].
32.
Weibel, ER.
Morphological basis of alveolar-capillary gas exchange.
Physiol Rev
53:
419-457,
1973[Free Full Text].
J APPL PHYSIOL 90(3):1049-1056
8750-7587/01 $5.00
Copyright © 2001 the American Physiological Society